INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP)

CUSIP: 46137V662

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / PHARMACEUTICALS
Total 13F shares
1,286,629
Share change
-67,911
Total reported value
$80,277,439
Price per share
$62.35
Number of holders
88
Value change
-$4,463,456
Number of buys
27
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 46137V662?
CUSIP 46137V662 identifies PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q4 2018

As of 31 Dec 2018, INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,286,629 shares. The largest 10 holders included MORGAN STANLEY, Peak Asset Management, LLC, LPL Financial LLC, BANK OF AMERICA CORP /DE/, MADISON INVESTMENT HOLDINGS INC, BAROMETER CAPITAL MANAGEMENT INC., COMMONWEALTH EQUITY SERVICES, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CIBC Private Wealth Group, LLC, and WELLS FARGO & COMPANY/MN. This page lists 88 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.